Full-Time

Quality Assurance Associate

Bimeda

Bimeda

1-10 employees

Global veterinary pharmaceuticals and animal health.

No salary listed

Pomona, CA, USA

In Person

Bachelor's

Category
Biology & Biotech (1)
Required Skills
Microsoft Office
Data Visualization
Quality Assurance (QA)

Get referred to Bimeda

See people who can refer or advise you

Requirements
  • A university degree in a related science field with specific Quality Assurance education or training is required.
  • Knowledge of pharmaceutical Quality Assurance methodologies, current Good Manufacturing Practice regulations, and quality systems is required.
  • Strong attention to detail, organizational skills, and the ability to manage timelines and priorities are required.
  • Proficiency in Microsoft Office and document management systems is required.
  • A minimum of 2–3 years of experience in pharmaceutical Quality Assurance systems, document control, and Good Manufacturing Practice compliance is required.
Responsibilities
  • Conduct Annual Product Reviews by analyzing production documentation, summarizing key issues and trends, and preparing final reports incorporating quality metrics and trending data where available.
  • Perform batch record review and determine batch disposition, including release, rejection, or hold, based on quality and risk impact; support risk-based, exception-driven batch review as electronic batch records are implemented.
  • Provide oversight and Quality Assurance approval for corrective and preventive action, deviation, and change control systems; monitor quality history and trends and recommend data-driven improvements.
  • Lead change control initiatives and facilitate documentation workflows in the electronic quality management system, supporting the site's transition to a fully electronic quality management system.
  • Administer and maintain Good Manufacturing Practice documents, including policies and corporate standard operating procedures, and quality records within ZenQMS.
  • Investigate product complaints, deviations, and out-of-specification results to determine root cause, quality impact, and corrective and preventive actions.
  • Perform internal Quality Assurance audits on manufacturing lines and finished products to verify compliance with corporate policies and Good Manufacturing Practice requirements.
  • Participate in regulatory, customer, and internal or mock audits; ensure timely completion and effectiveness verification of corrective actions.
  • Support site quality initiatives and inspection-readiness activities, including standard operating procedure framework reapproval and corrective and preventive action effectiveness tracking.
  • Ensure ongoing compliance with local, national, and international current Good Manufacturing Practice standards and legislation.
  • Support implementation and adoption of electronic quality management systems, laboratory information management systems, and electronic batch records, helping shift routine administrative work toward risk-based technical review and decision-making.
  • Use quality metrics, trend analysis, and dashboard or reporting tools, including artificial-intelligence-assisted quality analytics where available, to identify patterns, flag emerging risks, and inform data-driven decisions.
  • Champion quality culture initiatives such as Gemba walks, Quality Minutes, and Good Quality Catch recognition; support classification and reduction of human-error deviations.
  • Assist with development, simplification, and continuous improvement of departmental procedures, standard operating procedures, and best practices, focusing on reducing manual and administrative burden.
  • Identify opportunities to simplify, automate, or eliminate manual quality processes and challenge legacy ways of working in support of a leaner quality organization.
  • Support cross-training and knowledge-sharing efforts to reduce single-point dependencies and build a flexible, resilient quality team.
  • Collaborate with client-facing Quality Assurance representatives and cross-functional partners in Manufacturing, Quality Control, and Regulatory to ensure product and service quality and customer satisfaction.
  • Provide training and coaching to operators and supervisors on documentation practices, current Good Manufacturing Practice requirements, and evolving digital quality tools and workflows.
  • Communicate quality and documentation requirements clearly to internal teams and customers.
  • Promote quality achievement and continuous improvement across the organization and advocate for quality as a shared value in everyday decisions.
Desired Qualifications
  • Experience with electronic quality systems such as ZenQMS, TrackWise, or MasterControl, laboratory information management systems, or electronic batch record platforms.
  • Experience using data analytics, trending, dashboards, or artificial-intelligence-assisted quality tools to support risk-based decision-making.
  • Demonstrated experience supporting or driving process improvement, automation, or digital transformation initiatives in a regulated environment.
  • A track record of identifying and driving improvements to legacy processes as a change agent.
  • ASQ certification, including Certified Quality Auditor or Certified Quality Engineer, or equivalent quality certification.

Bimeda is a global veterinary pharmaceutical company that develops, manufactures, markets, and distributes animal health products. Its offerings range from medicines to wellness products for veterinarians, farmers, and animal health professionals, all aimed at improving animal health and wellbeing. The company supports its products with science from eight research and development laboratories, and distributes them in more than 80 countries. It grows through a mix of organic expansion and acquisitions, expanding its geographic reach and product lineup. A core focus is sustainability, integrating environmental and social responsibility into product development, delivery, and daily operations. Bimeda’s goal is to positively impact customers, communities, and the environment through collaboration, continuous improvement, and reliable animal health solutions.

Company Size

1-10

Company Stage

N/A

Total Funding

N/A

Headquarters

N/A

Founded

N/A

Get referred to Bimeda

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • GASTROBIM launched nationwide in May 2026, expanding Bimeda's fastest-growing omeprazole franchise.
  • Enhanced BOVitalize Plus debuted May 2026, strengthening cattle nutrition and performance sales.
  • Dr. Chris Olsen joined swine technical services, supporting autogenous vaccines and pharmaceuticals.

What critics are saying

  • GASTROBIM directly attacks Zoetis GastroGard, inviting immediate price compression in 2026.
  • Pomona integration creates execution risk, and Dechra supply handoffs can disrupt 2026 shipments.
  • If GASTROBIM stalls, Zoetis and Elanco keep Bimeda trapped in low-margin generics.

What makes Bimeda unique

  • Bimeda's April 2026 Pomona acquisition adds U.S. manufacturing capacity and supply control.
  • Its 2026 FDA-approved GASTROBIM matches GastroGard, targeting price-sensitive equine veterinarians.
  • Bimeda sells across 80 countries, pairing generic biosimilars with branded livestock support.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

401(k) Retirement Plan

Paid Vacation

Life Insurance

Employee Assistance Program

Paid Holidays

Company News

British Veterinary Association
Aug 4th, 2026
New treatment for bovine endometritis.

New treatment for bovine endometritis. 4 Aug 2026 11:00 AM Bimeda UK has launched Bimacure, which it says is the UK's first generic intrauterine cefapirin suspension for cattle, for the treatment of subacute and chronic endometritis. The formulation contains 500mg cefapirin per syringe and is for use in cows at least 14 days after parturition. It is supplied in packs of 10 sets each of syringes, administration catheters and gloves; the catheter and syringe connection have been designed to avoid 'pop offs' at critical moments. The firm says feedback about the product from other markets has been "extremely positive".

Feedstuffs
May 19th, 2026
Bimeda introduces enhanced BOVitalize Plus.

Bimeda introduces enhanced BOVitalize Plus. Product now fortified with A. oryzae to support cattle health, digestion and performance. May 19, 2026 Bimeda is proud to announce the launch of its newly enhanced BOVitalize Plus, now fortified with Aspergillus oryzae to deliver an even more comprehensive approach to cattle health, digestion and performance. This advancement builds on the trusted formulation of essential trace minerals and vitamins - selenium, copper, zinc, vitamin A and vitamin E - by adding targeted digestive support designed to help cattle get more from every bite of feed. For producers and veterinarians, the inclusion of A. oryzae represents a significant step forward in rumen efficiency. A oryzae provides enzymatic activity that enhances fiber breakdown, helping cattle maintain intake and digestive consistency during diet transitions, periods of stress or when forage quality declines. By supporting more efficient fiber utilization, the upgraded BOVitalize Plus helps optimize nutrient absorption, stabilize the rumen environment, and promote improved overall performance across all stages of production. This enhancement reflects its commitment to delivering solutions that truly support the challenges cattle face every day," said Dr. Eric Moore, head of technical services North America at Bimeda. "By combining key vitamins and minerals with the proven digestive benefits of Aspergillus oryzae - and refining how the formula performs in suspension - we're offering a more complete, performance-driven supplement designed to keep animals healthy, efficient and moving forward." The improved BOVitalize Plus continues to offer the same convenient oral dosing, eliminating the need for additional injections and reducing labor at the chute. With the added digestive benefits of A. oryzae, the product now delivers an even stronger value proposition for both cow-calf and stocker operations seeking to improve health, consistency and overall productivity. BOVitalize Plus is now available through authorized Bimeda distributors. Bimeda is a leading global manufacturer of animal health products used in more than 80 countries worldwide and is committed to providing innovative solutions that support livestock health, welfare and performance. Feedstuffs is the news source for animal agriculture

The Horse
May 6th, 2026
Bimeda(r) announces U.S. Availability of gastrobim(tm)(omeprazole) the first and only fda-approved bioequivalent to gastrogard(r)(omeprazole) for Equine Gastric Ulcer treatment.

Bimeda(r) announces U.S. Availability of gastrobim(tm)(omeprazole) the first and only fda-approved bioequivalent to gastrogard(r)(omeprazole) for Equine Gastric Ulcer treatment. Now available nationwide. Horse owners are encouraged to contact their veterinarian. Bimeda(R), a global leader in animal health solutions, today announced the U.S. launch of GASTROBIM(TM)(omeprazole), the first and only FDA-approved bioequivalent to GastroGard(R)(omeprazole) for the treatment and prevention of recurrence of gastric ulcers in horses and foals four weeks of age and older. This apple-flavored formulation offers veterinarians, trainers, and horse owners a clinically equivalent, high-quality alternative for the effective management of Equine Gastric Ulcer Syndrome (EGUS), addressing a critical need in equine health. Since its initial launch in 2024, GASTROBIM(TM) has rapidly emerged as the fastest-growing omeprazole product in Canada and Europe. Its strong adoption and positive reception among veterinarians and horse owners underscore its proven efficacy in treating and healing gastric ulcers, reinforcing its position as a trusted therapeutic option worldwide. The introduction of GASTROBIM(TM) in the U.S. further expands Bimeda's established equine portfolio, which includes leading brands such as EquiMAX(R)(1.87% ivermectin 14.03% praziquantel), Polyglycan(TM)(hyaluronic acid + chondroitin sulfates C4 & C6 + N-acetyl-D-glucosamine sterile solution), Detomequin(R)(detomidine hydrochloride), and Bimectin(R)(ivermectin paste), and reflects the company's ongoing commitment to delivering innovative, reliable solutions to the equine industry. "We are thrilled to introduce GASTROBIM(TM) to the U.S. market," said Eric Moore, DVM, Bimeda's Head of Technical Services North America. "Gastric ulcers remain one of the most common and performance limiting conditions in horses. Offering a bioequivalent, rigorously tested treatment underscores our commitment to supporting equine health, welfare, and performance at an affordable price." Equine Gastric Ulcer Syndrome (EGUS) affects a significant percentage of performance horses, often leading to reduced appetite, behavioral changes, discomfort, and decreased athletic performance. By introducing a bioequivalent, apple-flavored alternative, Bimeda aims to broaden access to effective treatment options and support improved health and performance outcomes across the equine industry.

American Association of Swine Veterinarians
Apr 15th, 2026
People on the move: dr. Chris Olsen.

People on the move: dr. Chris Olsen. Dr. Chris Olsen has joined Bimeda as their U.S. Swine Technical Service Veterinarian. In this role, he will support the growth of the company's swine autogenous vaccine business and provide technical expertise across its swine pharmaceutical portfolio. He was previously employed by Pharmacosmos. Dr. Olsen's updated contact information is available at aasv.org/directory. Are you on the move? Let Aasv Go know at [email protected].